Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $22.1600 (10.91%) ($18.7000 - $22.4100) on Wed. Mar. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.64% (three month average) | RSI | 35 | Latest Price | $22.1600(10.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -6.3% a day on average for past five trading days. | Weekly Trend | IOVA declines -19.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(51%) XBI(50%) ARKG(49%) IWO(46%) ARKK(44%) | Factors Impacting IOVA price | IOVA will decline at least -3.32% in a week (0% probabilities). VIXM(-31%) VXX(-16%) UUP(-9%) TLT(-3%) UNG(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.32% (StdDev 6.64%) | Hourly BBV | 0 () | Intraday Trend | 17.7% | | | |
|
1 - 5 Day Possible Target | $-7.44(-133.57%) | Resistance Level | $29.6 | 5 Day Moving Average | $22.19(-0.14%) | 10 Day Moving Average | $27.59(-19.68%) | 20 Day Moving Average | $29.6(-25.14%) | To recent high | -43% | To recent low | 13.4% | Market Cap | $3.245b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |